Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Well Corporation stock logo
AMWL
American Well
$8.07
$7.52
$6.10
$12.95
$125.97M1.2965,547 shs64,631 shs
Cano Health, Inc. stock logo
CANO
Cano Health
$3.81
$1.74
$190.00
$12.39M0.05423,785 shs159,142 shs
HilleVax, Inc. stock logo
HLVX
HilleVax
$2.05
-0.5%
$1.96
$1.34
$2.17
$103.29M0.76283,667 shs73,506 shs
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
$26.08
-1.2%
$24.62
$22.48
$71.71
$1.56B2.86874,675 shs720,588 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Well Corporation stock logo
AMWL
American Well
-0.47%-0.74%+17.90%+4.26%+3.86%
Cano Health, Inc. stock logo
CANO
Cano Health
0.00%0.00%0.00%0.00%0.00%
HilleVax, Inc. stock logo
HLVX
HilleVax
-0.49%-5.53%+10.22%+15.17%+15.82%
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
-1.21%-0.38%+10.51%-13.10%-41.63%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Well Corporation stock logo
AMWL
American Well
2.6961 of 5 stars
2.14.00.00.03.42.51.3
Cano Health, Inc. stock logo
CANO
Cano Health
N/AN/AN/AN/AN/AN/AN/AN/A
HilleVax, Inc. stock logo
HLVX
HilleVax
1.7043 of 5 stars
1.05.00.00.00.03.31.3
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
2.6166 of 5 stars
3.51.00.00.02.54.20.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Well Corporation stock logo
AMWL
American Well
2.14
Hold$9.6719.79% Upside
Cano Health, Inc. stock logo
CANO
Cano Health
0.00
N/AN/AN/A
HilleVax, Inc. stock logo
HLVX
HilleVax
2.00
Hold$2.00-2.44% Downside
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
3.08
Buy$91.89252.33% Upside

Current Analyst Ratings Breakdown

Latest CANO, HLVX, JANX, and AMWL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/11/2025
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$65.00
5/23/2025
American Well Corporation stock logo
AMWL
American Well
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$10.00 ➝ $8.00
5/8/2025
American Well Corporation stock logo
AMWL
American Well
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$12.00 ➝ $9.00
5/2/2025
American Well Corporation stock logo
AMWL
American Well
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$10.00 ➝ $8.00
5/2/2025
American Well Corporation stock logo
AMWL
American Well
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 7/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Well Corporation stock logo
AMWL
American Well
$254.36M0.50N/AN/A$20.31 per share0.40
Cano Health, Inc. stock logo
CANO
Cano Health
$2.74B0.00N/A0.03$100.28 per share0.00
HilleVax, Inc. stock logo
HLVX
HilleVax
N/AN/AN/AN/A$3.10 per shareN/A
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
$10.59M145.72N/AN/A$19.49 per share1.34
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Well Corporation stock logo
AMWL
American Well
-$208.14M-$10.19N/AN/AN/A-59.13%-48.36%-35.36%7/30/2025 (Estimated)
Cano Health, Inc. stock logo
CANO
Cano Health
-$207.27M-$215.87N/AN/AN/A-18.62%-133.59%-19.18%N/A
HilleVax, Inc. stock logo
HLVX
HilleVax
-$147.27M-$2.15N/AN/AN/AN/A-51.86%-41.45%8/14/2025 (Estimated)
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
-$68.99M-$1.36N/AN/AN/AN/A-9.29%-8.89%8/6/2025 (Estimated)

Latest CANO, HLVX, JANX, and AMWL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
HilleVax, Inc. stock logo
HLVX
HilleVax
-$0.14N/AN/AN/AN/AN/A
8/6/2025Q2 2025
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
-$0.50N/AN/AN/A$0.30 millionN/A
7/30/2025Q2 2025
American Well Corporation stock logo
AMWL
American Well
-$1.90N/AN/AN/A$63.87 millionN/A
5/8/2025Q1 2025
HilleVax, Inc. stock logo
HLVX
HilleVax
-$0.37-$0.12+$0.25-$0.12N/AN/A
5/8/2025Q1 2025
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
-$0.43-$0.38+$0.05-$0.38$0.59 millionN/A
5/1/2025Q1 2025
American Well Corporation stock logo
AMWL
American Well
-$3.09-$1.73+$1.36-$1.19$60.15 million$66.83 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Well Corporation stock logo
AMWL
American Well
N/AN/AN/AN/AN/A
Cano Health, Inc. stock logo
CANO
Cano Health
N/AN/AN/AN/AN/A
HilleVax, Inc. stock logo
HLVX
HilleVax
N/AN/AN/AN/AN/A
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Well Corporation stock logo
AMWL
American Well
N/A
2.92
2.89
Cano Health, Inc. stock logo
CANO
Cano Health
3.95
0.40
0.40
HilleVax, Inc. stock logo
HLVX
HilleVax
N/A
25.32
25.32
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
N/A
58.47
58.47

Institutional Ownership

CompanyInstitutional Ownership
American Well Corporation stock logo
AMWL
American Well
56.05%
Cano Health, Inc. stock logo
CANO
Cano Health
35.99%
HilleVax, Inc. stock logo
HLVX
HilleVax
86.42%
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
75.39%

Insider Ownership

CompanyInsider Ownership
American Well Corporation stock logo
AMWL
American Well
12.80%
Cano Health, Inc. stock logo
CANO
Cano Health
13.93%
HilleVax, Inc. stock logo
HLVX
HilleVax
24.90%
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
29.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Well Corporation stock logo
AMWL
American Well
1,04015.61 million13.61 millionOptionable
Cano Health, Inc. stock logo
CANO
Cano Health
4,3655.41 million4.65 millionOptionable
HilleVax, Inc. stock logo
HLVX
HilleVax
2050.14 million37.66 millionNot Optionable
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
3059.17 million41.78 millionOptionable

Recent News About These Companies

Janux Therapeutics Becomes Oversold (JANX)

New MarketBeat Followers Over Time

Media Sentiment Over Time

American Well stock logo

American Well NYSE:AMWL

$8.07 0.00 (0.00%)
Closing price 07/21/2025
Extended Trading
$8.02 -0.05 (-0.57%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Cano Health stock logo

Cano Health NYSE:CANO

Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.

HilleVax stock logo

HilleVax NASDAQ:HLVX

$2.05 -0.01 (-0.53%)
As of 07/21/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

Janux Therapeutics stock logo

Janux Therapeutics NASDAQ:JANX

$26.08 -0.32 (-1.21%)
Closing price 07/21/2025 04:00 PM Eastern
Extended Trading
$26.14 +0.07 (+0.25%)
As of 07:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company's clinical candidates comprise JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Its development pipeline also consists of discovery stage products. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.